GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **901 - 925** of **4050** in total

« First

‹ Prev

…

33

34

35

36

37

38

39

40

41

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▼
IgA	Patient 4	12	mild	G30839DN	463
IgG	Patient 4	12	mild	G19118WX	463
IgM	Patient 2	15	mild	G10133VD	462
IgM	Patient 2	15	mild	G82204SH	462
IgA	Patient 2	3	mild	G15209MJ	462
IgM	Patient 2	3	mild	G91537AT	462
IgA	Patient 2	15	mild	G26125KY	461
IgA	Patient 2	24	mild	G15209MJ	461
IgA	Patient 3	4	mild	G08520NM	461
IgA	Patient 3	4	mild	G22768VO	461
IgA	Patient 4	12	mild	G54064FW	461
IgA	Patient 1	10	moderate	G39023AU	460
IgA	Patient 2	24	mild	G66937TJ	460
IgA	Patient 4	12	mild	G00066MO	460
IgA	Patient 1	22	moderate	G60761LT	459
IgA	Patient 1	6	moderate	G99603GB	459
IgA	Patient 2	24	mild	G60761LT	459
IgG	Patient 2	15	mild	G15209MJ	459
IgA	Patient 3	11	mild	G18057VI	459
IgA	Patient 4	12	mild	G26125KY	459
IgA	Patient 2	15	mild	G61399NC	458
IgA	Patient 2	24	mild	G14569AR	458
IgA	Patient 3	4	mild	G21320TF	458
IgA	Patient 3	4	mild	G67045LB	458
IgA	Patient 2	24	mild	G82204SH	457